Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP930025.RASWhq3GVR_-I1O-L6lUKdaswZr58Op9NX00-OssnwHVw130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP930025.RASWhq3GVR_-I1O-L6lUKdaswZr58Op9NX00-OssnwHVw130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP930025.RASWhq3GVR_-I1O-L6lUKdaswZr58Op9NX00-OssnwHVw130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP930025.RASWhq3GVR_-I1O-L6lUKdaswZr58Op9NX00-OssnwHVw130_provenance.
- NP930025.RASWhq3GVR_-I1O-L6lUKdaswZr58Op9NX00-OssnwHVw130_assertion description "[Dual therapy with the nonstructural protein 5A inhibitor, daclatasvir, and the nonstructural protein 3 protease inhibitor, asunaprevir, in hepatitis C virus genotype 1b-infected null responders.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP930025.RASWhq3GVR_-I1O-L6lUKdaswZr58Op9NX00-OssnwHVw130_provenance.
- NP930025.RASWhq3GVR_-I1O-L6lUKdaswZr58Op9NX00-OssnwHVw130_assertion evidence source_evidence_literature NP930025.RASWhq3GVR_-I1O-L6lUKdaswZr58Op9NX00-OssnwHVw130_provenance.
- NP930025.RASWhq3GVR_-I1O-L6lUKdaswZr58Op9NX00-OssnwHVw130_assertion SIO_000772 21987462 NP930025.RASWhq3GVR_-I1O-L6lUKdaswZr58Op9NX00-OssnwHVw130_provenance.
- NP930025.RASWhq3GVR_-I1O-L6lUKdaswZr58Op9NX00-OssnwHVw130_assertion wasDerivedFrom befree-2016 NP930025.RASWhq3GVR_-I1O-L6lUKdaswZr58Op9NX00-OssnwHVw130_provenance.
- NP930025.RASWhq3GVR_-I1O-L6lUKdaswZr58Op9NX00-OssnwHVw130_assertion wasGeneratedBy ECO_0000203 NP930025.RASWhq3GVR_-I1O-L6lUKdaswZr58Op9NX00-OssnwHVw130_provenance.
- befree-2016 importedOn "2016-02-19" NP930025.RASWhq3GVR_-I1O-L6lUKdaswZr58Op9NX00-OssnwHVw130_provenance.